Vascular Closure Devices Market Report 2025

This report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The vascular closure devices market size has grown strongly in recent years. It will grow from $1.53 billion in 2024 to $1.63 billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to growth in minimally invasive procedures, aging population demographics, patient preference for shorter recovery times, increased catheterization lab procedures, focus on outpatient care.

The vascular closure devices market size is expected to see strong growth in the next few years. It will grow to $2.11 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to rise in ambulatory surgery centers, shift toward same-day discharge, patient-centric approaches, healthcare cost containment initiatives, increasing incidence of cardiovascular diseases. Major trends in the forecast period include adoption of percutaneous coronary intervention, global collaboration in medical research, remote patient monitoring, integration with imaging technologies, technological innovations in device design.

The expected surge in the prevalence of cardiovascular diseases is projected to significantly propel the growth of the vascular closure devices (VCDs) market. Cardiovascular diseases (CVDs) encompass a spectrum of conditions impacting the heart or blood vessels, disrupting normal blood circulation in the heart. VCDs serve as an alternative to traditional mechanical compression, swiftly sealing the femoral artery access point. This expedites the achievement of hemostasis and mitigates the risk of post-procedural bleeding or hemorrhaging. As an illustration, data from the Immigration and Checkpoints Authority in June 2023 indicated a rise in fatalities attributed to heart and hypertensive diseases in Singapore, escalating from 6,238 in 2021 to 6,884 in 2022. Consequently, the escalating prevalence of cardiovascular diseases is anticipated to be a major driver propelling the expansion of the vascular closure devices market.

The growing prevalence of obesity is expected to drive the expansion of the vascular closure devices market. Obesity is a medical condition characterized by an excessive accumulation of body fat that negatively affects health, resulting from an imbalance between calories consumed and calories expended. Vascular closure devices are used in overweight and obese patients to reduce the risk of bleeding complications and to address challenges arising from anatomical factors and potential complications due to excess adipose tissue during medical procedures. For example, in March 2023, the World Heart Foundation, a Switzerland-based global cardiovascular organization, reported that approximately 2.3 billion adults and children worldwide are obese or overweight. With the current trends, it is projected that the number of people living with obesity will reach 2.7 billion by 2025. As a result, the increasing prevalence of obesity is driving the growth of the vascular closure devices market.

Major companies in the vascular closure devices market are focusing on developing technologies like innovative collapsible disc technology to improve patient outcomes, reduce recovery times, and enhance the overall effectiveness and ease of vascular procedures. This innovative collapsible disc technology features a design that allows the disc to be easily collapsed and expanded for efficient storage and portability, increasing convenience and versatility in various applications such as sporting goods, outdoor gear, and packaging solutions. For example, in June 2024, Haemonetics Corporation, a US-based medical technology company, launched the VASCADE MVP XL. This mid-bore vascular closure device incorporates 58% more collagen and a larger disc compared to its predecessor, the VASCADE MVP system. The new design aims to provide a more robust closure solution, ensuring quicker recovery and better patient outcomes.

In October 2023, Cordis Corporation, a US-based global medical company, acquired M.A. Med Alliance SA for an undisclosed amount. This acquisition allows Cordis Corporation to expand its product portfolio and strengthen its position in the medical device market. M.A. Med Alliance SA, a Sweden-based medical technology company, specializes in creating innovative solutions for vascular interventions.

Major companies operating in the vascular closure devices market report are Cardinal Health Inc., Abbott Laboratories, Medtronic PLC, Koninklijke Philips NV, Boston Scientific Corporation, Terumo Corporation, C.R. Bard Inc., Cook Medical Inc., W. L. Gore & Associates Inc., Maquet Getinge Group, Teleflex Inc., BTG International Inc., Biotronik GMBH & CO.KG, Merit Medical System Inc., Vygon SA, Cardiovascular Systems Inc., Sirtex Medical Limited, Endologix LLC, TZ Medical Inc., Cardiva Medical Inc., Essential Medical Inc., KOAG LLC, Morris Innovative Inc., Vasorum Ltd., Scion BioMedical Inc., Z-Media LLC, Advanced Vascular Dynamics, Transluminal Technologies Inc., Tricol Medical Inc.

North America was the largest region in the vascular closure devices market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vascular closure devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the vascular closure devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The vascular closure devices market consists of sales of clip-based devices, suture-based devices, plug-based devices, and compression devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Vascular closure devices are medical devices designed to seal the entry point in an artery following a catheterization procedure, minimizing the risk of complications such as bleeding or hematoma formation. These devices accelerate the natural healing process at the access site.

The primary categories of vascular closure devices include passive approximators, active approximators, and external hemostatic devices. Passive approximators involve the use of plugs, sealants, or gels at the arteriotomy site without physically closing the arteriotomy. These devices are utilized for femoral and radial access procedures and find applications in acute care facilities, hospitals, clinics, and other healthcare settings.

The vascular closure devices market research report is one of a series of new reports that provides vascular closure devices market statistics, including vascular closure devices industry global market size, regional shares, competitors with a vascular closure devices market share, detailed vascular closure devices market segments, market trends and opportunities, and any further data you may need to thrive in the vascular closure devices industry. This vascular closure devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.